查詢結果分析
相關文獻
- 應用噁心嘔吐量表於癌症病童之經驗
- Validity of Two Instruments Measuring Nausea and Vomiting by Children Who Received Cancer Chemotherapy
- Serotonin Receptor Antagonists用來治療噁心、嘔吐
- 噁心和嘔吐的處置
- Prevention of PONV with Dexamethasone in Female Patients Undergoing Desflurane Anesthesia for Thyroidectomy
- Prevention of Acute and Delayed Cisplatin-Induced Nausea and Vomiting with Intravenous Ondansetron Plus Intravenous Dexamethasone
- 噁心嘔吐之居家照護
- 婦女孕期噁心嘔吐之內心感受與護理需求
- 噁心嘔吐量表在婦癌病患的應用
- Comparison of Intravenous Granisetron with Metoclopramide Plus Dexamethasone in the Prevention of Nausea and Vomiting Associated with Emetogenic Cytotoxic Chemotherapy
頁籤選單縮合
題 名 | Prevention of Acute and Delayed Cisplatin-Induced Nausea and Vomiting with Intravenous Ondansetron Plus Intravenous Dexamethasone=以靜脈滴注Ondansetron 及 Dexamethasone來預防Cisplatin 引發之急性及延遲性嘔吐和噁心 |
---|---|
作 者 | 廖宗琦; 王正旭; 張獻崑; 高振益; 黃仁聖; | 書刊名 | 長庚醫學 |
卷 期 | 23:7 2000.07[民89.07] |
頁 次 | 頁413-419 |
分類號 | 418.243 |
關鍵詞 | 噁心; 嘔吐; Cisplatin; Ondansetron; Dexamethasone; Nausea; Vomiting; |
語 文 | 英文(English) |
英文摘要 | Background. We conducted a prospective study to evaluate the anti-emetic effect of cisplatin-induced nausea and vomiting with intravenous (IV) ondansetron plus IV dexamethasone. Methods. One hundred forty-six chemotherapy (CT)-naive patients were enrolled in the study. They were scheduled to receive cisplatin 50 to 100 mg/m2 (mean, 53 mg/m2) on day 1 followed immediately by continuous infusion of 5-fluorouracil with or without other CT agents on the subsequent days. Three 8 mg doses of ondansetron IV were given at 4-hour intervals plus 20 mg dexamethasone IV infusions from the start of CT, followed by 5 mg dexamethasone IV every 12 hours, and the administration of dexamethasone was discontinued after the completion of CT. Results. The rates of complete protection from acute and delayed vomiting/nausea obtained in these patients were 97.3%/93.2% and 71.2%/60.3%, respectively. The rates of complete protection from both acute and delayed nausea were 70.5% and 58.9%, respectively. By comparison, the total control rate of vomiting was less in female patients than in male patients (p=0.017), and the total control rate of nausea was lower in the age group less than 50 years (p=0.045). The time from the start of CT to the onset of nausea appeared to be earlier than that for vomiting (log-rank test, p=0.045). Adverse events tended to be minor, with constipation and hiccups as the most common. Conclusion. These results indicate that IV ondansetron plus IV dexamethasone is a feasible anti-emetic therapy in an inpatient setting. IV ondansetron plus IV dexamethasone is highly effective in preventing acute cisplatin-induced nausea and vomiting. |
本系統中英文摘要資訊取自各篇刊載內容。